Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.57 - $1.16 $233,402 - $474,994
409,478 New
409,478 $249,000
Q4 2022

Feb 14, 2023

BUY
$1.4 - $25.4 $138,040 - $2.5 Million
98,600 New
98,600 $143,000
Q2 2022

Aug 15, 2022

SELL
$12.3 - $27.3 $135,226 - $300,136
-10,994 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$16.6 - $32.3 $135,937 - $264,504
-8,189 Reduced 42.69%
10,994 $28,000
Q4 2021

Feb 14, 2022

SELL
$29.9 - $61.2 $2.3 Million - $4.7 Million
-76,780 Reduced 80.01%
19,183 $57,000
Q3 2021

Nov 15, 2021

BUY
$51.4 - $68.2 $2.23 Million - $2.96 Million
43,453 Added 82.75%
95,963 $528,000
Q2 2021

Aug 16, 2021

SELL
$44.1 - $84.0 $9.73 Million - $18.5 Million
-220,662 Reduced 80.78%
52,510 $385,000
Q1 2021

May 17, 2021

BUY
$47.0 - $155.7 $11.8 Million - $39 Million
250,558 Added 1107.98%
273,172 $2.21 Million
Q4 2020

Feb 16, 2021

BUY
$4.8 - $30.8 $108,547 - $696,511
22,614 New
22,614 $70,000

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $58M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.